Artificial Intelligence Becomes the Top Global Healthcare IT Investment Priority, KLAS Report Finds

Executive Summary

The KLAS Global HIT Trends 2026 report reveals a historic shift in healthcare technology investment: artificial intelligence (AI) has emerged as the top priority across all international regions, with 57% of healthcare organizations ranking it as their primary focus. Ambient clinical voice technologies lead AI adoption, capturing 57% of emerging tech mindshare. Cloud adoption has reached 73%, driven by the need to support AI workloads, while consulting engagement has plummeted to 25% as organizations prioritize internal capabilities amid economic pressures.

Scientific and Technological Advancement

The rapid advancement of AI in healthcare—particularly natural language processing for ambient clinical documentation and machine learning for diagnostic imaging—has moved from experimental to operational. These technologies are now being deployed in clinical settings to reduce physician burnout, improve diagnostic accuracy, and optimize operational efficiency.

Why It Matters

Healthcare systems globally face unprecedented challenges: labor shortages, rising multi-morbidity patient volumes, and operational margin compression. AI offers a pathway to alleviate these pressures by automating routine tasks, enhancing clinical decision-making, and enabling more efficient resource allocation.

Research Findings

The KLAS report, based on survey data from 182 healthcare organizations in 43 countries, found:

AI is the top investment priority in every measured region, with 57% of leaders citing it as their primary focus.
Ambient clinical voice technology dominates, with 57% of organizations exploring or deploying it.
Cloud adoption has surged to 73%, with Microsoft Azure leading at 56% mindshare, followed by Oracle Cloud Infrastructure (16%).
Consulting engagement has dropped to a 25% low, with 42% of organizations planning no external advisory support.
Core AI strategy and governance are prioritized by 37% of organizations before tool deployment.

Industry Impact

This shift has profound implications for the biotechnology and life sciences sectors. AI-driven drug discovery, clinical trial optimization, and precision medicine are expected to benefit from the broader healthcare IT investment surge. However, the contraction in consulting spending suggests a move toward in-house AI capabilities, potentially slowing the adoption of specialized biotech AI platforms unless they demonstrate clear ROI.

Clinical and Regulatory Perspective

While AI adoption accelerates, regulatory bodies face challenges in ensuring safety, efficacy, and data privacy. The emphasis on governance frameworks by 37% of organizations indicates a cautious approach. Ambient clinical voice technologies, which reduce documentation burden, have shown clinical utility and are among the most regulated AI applications in healthcare, with clear guidelines from agencies like FDA and EMA for software as a medical device.

Future Outlook

Over the next 5–15 years, AI is expected to become deeply embedded in clinical workflows, from diagnostics to treatment planning. The convergence of AI with genomics, synthetic biology, and biomanufacturing will likely drive new therapeutic modalities. Cloud infrastructure will continue to evolve to support large-scale AI models, while the decline in consulting may spur growth in specialized AI-as-a-service platforms. Organizations that successfully integrate AI now will have a competitive advantage in delivering precision medicine and improving population health.

Key Takeaways

AI is the top healthcare IT investment priority globally, with 57% of organizations leading the charge.
Ambient clinical voice technology is the most common entry point for AI adoption.
Cloud adoption is accelerating to support AI, with 73% of organizations using public or hybrid clouds.
External consulting engagement has hit a four-year low as organizations build internal AI expertise.
The biotech industry should monitor these trends for opportunities in AI-powered drug discovery and clinical research.

Sources

KLAS Research. (2026). Global HIT Trends 2026: The AI Surge Continues. https://klasresearch.com/report/global-hit-trends-2026-the-ai-surge-continues/3976